154 related articles for article (PubMed ID: 8679254)
1. Twenty years with monoclonal antibodies: State of the art--Where do we go?
Stigbrand T; Ullén A; Sandstrom P; Mirzaie-Joniani H; Sundström B; Nillson B; Arlestig L; Norrlund RR; Ahlström KR; Hietala S
Acta Oncol; 1996; 35(3):259-65. PubMed ID: 8679254
[TBL] [Abstract][Full Text] [Related]
2. [Radioimmunoscintigraphy and radioimmunotherapy--approaches towards future aspects].
Nakamura K
Kaku Igaku; 1994 Sep; 31(9):1133-40. PubMed ID: 7967199
[TBL] [Abstract][Full Text] [Related]
3. Radioimmunodetection of solid tumors. Future horizons and applications for radioimmunotherapy.
McKearn TJ
Cancer; 1993 Jun; 71(12 Suppl):4302-13. PubMed ID: 8508392
[TBL] [Abstract][Full Text] [Related]
4. Radioimmunotherapy of solid tumors: from fairytale to reality.
Adams GP; Weiner LM
Cancer Biother Radiopharm; 2001 Feb; 16(1):9-11. PubMed ID: 11279802
[No Abstract] [Full Text] [Related]
5. Radioimmunodetection and therapy of breast cancer.
DeNardo SJ
Semin Nucl Med; 2005 Apr; 35(2):143-51. PubMed ID: 15765377
[TBL] [Abstract][Full Text] [Related]
6. Secondary antibodies as tools to improve tumor to non tumor ratio at radioimmunolocalisation and radioimmunotherapy.
Ullén A; Ahlström KR; Heitala S; Nilsson B; Arlestig L; Stigbrand T
Acta Oncol; 1996; 35(3):281-5. PubMed ID: 8679257
[TBL] [Abstract][Full Text] [Related]
7. Monoclonal antibodies: old and new trends in breast cancer imaging and therapeutic approach.
Stipsanelli E; Valsamaki P
Hell J Nucl Med; 2005; 8(2):103-8. PubMed ID: 16142251
[TBL] [Abstract][Full Text] [Related]
8. Radioimmunotherapy and colorectal cancer.
Koppe MJ; Bleichrodt RP; Oyen WJ; Boerman OC
Br J Surg; 2005 Mar; 92(3):264-76. PubMed ID: 15739250
[TBL] [Abstract][Full Text] [Related]
9. BIS-1: a novel bispecific monoclonal antibody for CEA-expressing carcinoma radioimmunoscintigraphy and radioimmunotherapy.
Parisi A; Bartolazzi A; Bonino C; Camagna M; DeMonte LB; Lombardi A; Natali PG; Paganelli G; Tarditi L; Vassarotto C
Year Immunol; 1993; 7():96-105. PubMed ID: 8372516
[No Abstract] [Full Text] [Related]
10. Radioimmunotherapy for model B cell malignancies using 90Y-labeled anti-CD19 and anti-CD20 monoclonal antibodies.
Ma D; McDevitt MR; Barendswaard E; Lai L; Curcio MJ; Pellegrini V; Brechbiel MW; Scheinberg DA
Leukemia; 2002 Jan; 16(1):60-6. PubMed ID: 11840264
[TBL] [Abstract][Full Text] [Related]
11. New insights into the pretargeting approach to image and treat tumours.
Patra M; Zarschler K; Pietzsch HJ; Stephan H; Gasser G
Chem Soc Rev; 2016 Nov; 45(23):6415-6431. PubMed ID: 27722526
[TBL] [Abstract][Full Text] [Related]
12. Monoclonal antibody Po66 uptake by human lung tumours implanted in nude mice: effect of co-administration with doxorubicin.
Desrues B; Léna H; Brichory F; Ramée MP; Toujas L; Delaval P; Dazord L
Br J Cancer; 1995 Nov; 72(5):1076-82. PubMed ID: 7577450
[TBL] [Abstract][Full Text] [Related]
13. Radiolabelled monoclonal antibodies in oncology. III. Radioimmunotherapy.
Britton KE; Mather SJ; Granowska M
Nucl Med Commun; 1991 Apr; 12(4):333-47. PubMed ID: 2067740
[TBL] [Abstract][Full Text] [Related]
14. Combined radioimmunotherapy and chemotherapy of breast tumors with Y-90-labeled anti-Her2 and anti-CEA antibodies with taxol.
Crow DM; Williams L; Colcher D; Wong JY; Raubitschek A; Shively JE
Bioconjug Chem; 2005; 16(5):1117-25. PubMed ID: 16173788
[TBL] [Abstract][Full Text] [Related]
15. The present and future of radiolabelled antibodies in oncology.
Britton KE; Granowska M
Ann Nucl Med; 1993 Aug; 7(3):127-32. PubMed ID: 8217486
[No Abstract] [Full Text] [Related]
16. Radiolabelled monoclonal antibodies in tumour imaging and therapy: out of fashion?
Delaloye AB; Delaloye B
Eur J Nucl Med; 1995 Jun; 22(6):571-80. PubMed ID: 7556306
[TBL] [Abstract][Full Text] [Related]
17. A simple method to determine the immunoreactivity of radiolabelled monoclonal antibodies to the TAG-72 antigen.
Ngai WM; Reilly RM
Appl Radiat Isot; 1993 Sep; 44(9):1193-7. PubMed ID: 8401449
[TBL] [Abstract][Full Text] [Related]
18. Antibody-guided radiation therapy of cancer.
Koppe MJ; Postema EJ; Aarts F; Oyen WJ; Bleichrodt RP; Boerman OC
Cancer Metastasis Rev; 2005 Dec; 24(4):539-67. PubMed ID: 16408161
[TBL] [Abstract][Full Text] [Related]
19. Therapy and imaging of pancreatic carcinoma xenografts with radioiodine-labeled chimeric monoclonal antibody A10 and its Fab fragment.
Kamigaki T; Yamamoto M; Ohyanagi H; Ohya M; Shimazoe T; Kono A; Ohtani W; Narita Y; Ohkubo M; Saitoh Y
Jpn J Cancer Res; 1995 Dec; 86(12):1216-23. PubMed ID: 8636013
[TBL] [Abstract][Full Text] [Related]
20. Carcinoembryonic antigen as a target cancer antigen for radiolabeled antibodies: prospects for cancer imaging and therapy.
Goldenberg DM
Tumour Biol; 1995; 16(1):62-73. PubMed ID: 7863224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
